NIH-funded research R01 grant

How the Lyme bacterium survives oxidative stress to cause infection

Official title: Redox Regulation of DksA-dependent Borrelia burgdorferi infectivity

Funded at Creighton University · NIH-11141142 · Data updated 2026-11-12

This project looks at how the Lyme disease bacterium uses a regulator called DksA to survive oxidative and nitrosative stress, which could matter for people with or at risk for Lyme disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCreighton University
NIH-funded
Lab location1 site (Omaha, United States)
Project startAugust 1, 2023
Project endJuly 31, 2027
Funding year2025
Award (this year)$430,347
NIH project number5R01AI167880-03
Project IDNIH-11141142 on NIH RePORTER

Who could benefit from this research

Could help

Although this laboratory-focused project does not enroll patients, people with current or prior Lyme disease and those frequently exposed to tick bites are the groups most likely to benefit from future clinical work informed by these findings.

Less likely to help

People seeking immediate new treatments or those with non-Lyme conditions are unlikely to see direct, short-term benefits from this basic science grant.

What this research studies

Researchers will study the Lyme bacterium Borrelia burgdorferi in the lab to see how the DksA protein and modifications of cysteine residues respond to reactive oxygen and nitrogen species. They will use bacterial genetics, biochemical assays, and infection models in ticks and mammals to link molecular changes to the bacteria's ability to infect. The team will measure how oxidative and nitrosative stress affect gene regulation, antioxidant defenses, and central metabolism in the bacteria. Results aim to reveal bacterial survival mechanisms that could become targets for future prevention or treatment strategies.

Why it matters

Potential benefit: If successful, this work could identify bacterial mechanisms to target for new treatments or ways to prevent Lyme disease.

How similar studies have gone: Prior laboratory studies have shown DksA controls gene expression and that reactive oxygen/nitrogen species modify bacterial proteins, but linking these modifications to infectivity is a newer and less-tested area.

Where this research is happening

  • Creighton University
    Omaha, United States
    Active

Researchers

  • Principal investigator: Bourret, Travis J — Creighton University
  • Study coordinator: Bourret, Travis J

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.